Globus Medical EBITDA Margin 2010-2024 | GMED
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Globus Medical (GMED) over the last 10 years. The current EBITDA margin for Globus Medical as of September 30, 2024 is .
| Globus Medical EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $2.48B | $0.62B | 25.04% |
| 2024-06-30 | $2.24B | $0.50B | 22.16% |
| 2024-03-31 | $1.90B | $0.41B | 21.47% |
| 2023-12-31 | $1.57B | $0.36B | 22.87% |
| 2023-09-30 | $1.23B | $0.29B | 23.55% |
| 2023-06-30 | $1.10B | $0.31B | 28.35% |
| 2023-03-31 | $1.07B | $0.31B | 29.19% |
| 2022-12-31 | $1.02B | $0.30B | 29.52% |
| 2022-09-30 | $1.00B | $0.27B | 26.63% |
| 2022-06-30 | $0.98B | $0.26B | 26.46% |
| 2022-03-31 | $0.96B | $0.24B | 24.74% |
| 2021-12-31 | $0.96B | $0.25B | 25.57% |
| 2021-09-30 | $0.94B | $0.29B | 30.29% |
| 2021-06-30 | $0.93B | $0.28B | 30.20% |
| 2021-03-31 | $0.83B | $0.20B | 24.73% |
| 2020-12-31 | $0.79B | $0.18B | 22.18% |
| 2020-09-30 | $0.77B | $0.16B | 21.22% |
| 2020-06-30 | $0.75B | $0.15B | 20.32% |
| 2020-03-31 | $0.79B | $0.22B | 27.33% |
| 2019-12-31 | $0.79B | $0.22B | 28.37% |
| 2019-09-30 | $0.77B | $0.21B | 27.79% |
| 2019-06-30 | $0.74B | $0.21B | 27.99% |
| 2019-03-31 | $0.72B | $0.21B | 28.57% |
| 2018-12-31 | $0.71B | $0.21B | 29.92% |
| 2018-09-30 | $0.69B | $0.22B | 31.21% |
| 2018-06-30 | $0.68B | $0.21B | 31.70% |
| 2018-03-31 | $0.65B | $0.21B | 32.11% |
| 2017-12-31 | $0.64B | $0.21B | 32.70% |
| 2017-09-30 | $0.61B | $0.21B | 33.82% |
| 2017-06-30 | $0.60B | $0.21B | 34.56% |
| 2017-03-31 | $0.58B | $0.20B | 34.94% |
| 2016-12-31 | $0.56B | $0.20B | 35.28% |
| 2016-09-30 | $0.56B | $0.21B | 36.94% |
| 2016-06-30 | $0.56B | $0.21B | 37.23% |
| 2016-03-31 | $0.55B | $0.21B | 37.07% |
| 2015-12-31 | $0.55B | $0.20B | 36.63% |
| 2015-09-30 | $0.53B | $0.18B | 34.40% |
| 2015-06-30 | $0.51B | $0.18B | 34.31% |
| 2015-03-31 | $0.49B | $0.17B | 34.48% |
| 2014-12-31 | $0.48B | $0.16B | 34.32% |
| 2014-09-30 | $0.46B | $0.16B | 33.62% |
| 2014-06-30 | $0.45B | $0.15B | 33.11% |
| 2014-03-31 | $0.44B | $0.13B | 28.89% |
| 2013-12-31 | $0.43B | $0.12B | 28.57% |
| 2013-09-30 | $0.42B | $0.12B | 28.57% |
| 2013-06-30 | $0.41B | $0.12B | 28.68% |
| 2013-03-31 | $0.40B | $0.14B | 34.01% |
| 2012-12-31 | $0.39B | $0.13B | 34.37% |
| 2012-09-30 | $0.37B | $0.13B | 33.96% |
| 2012-06-30 | $0.36B | $0.13B | 34.71% |
| 2012-03-31 | $0.35B | $0.12B | 34.20% |
| 2011-12-31 | $0.33B | $0.11B | 34.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $12.635B | $1.568B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.348B | 26.52 |
| Intuitive Surgical (ISRG) | United States | $203.988B | 93.58 |
| Alcon (ALC) | Switzerland | $45.073B | 30.16 |
| Edwards Lifesciences (EW) | United States | $41.952B | 26.64 |
| IQVIA Holdings (IQV) | United States | $35.950B | 19.81 |
| IDEXX Laboratories (IDXX) | United States | $34.289B | 40.38 |
| DexCom (DXCM) | United States | $33.759B | 50.84 |
| Waters (WAT) | United States | $23.998B | 35.49 |
| STERIS (STE) | Ireland | $21.743B | 25.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.798B | 0.00 |
| Hologic (HOLX) | United States | $16.119B | 17.50 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.577B | 14.96 |
| Sysmex ADR (SSMXY) | Japan | $12.243B | 38.39 |
| Penumbra (PEN) | United States | $10.352B | 101.40 |
| Masimo (MASI) | United States | $9.509B | 46.01 |
| Glaukos (GKOS) | United States | $8.767B | 0.00 |
| Teleflex (TFX) | United States | $8.387B | 13.38 |
| Integer Holdings (ITGR) | United States | $4.804B | 27.23 |
| Inari Medical (NARI) | United States | $4.666B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.807B | 0.00 |
| Veracyte (VCYT) | United States | $3.444B | 103.35 |
| LivaNova (LIVN) | United Kingdom | $2.755B | 15.90 |
| Nihon Kohden (NHNKY) | Japan | $2.554B | 19.40 |
| Tandem Diabetes Care (TNDM) | United States | $2.388B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.309B | 20.76 |
| TransMedics (TMDX) | United States | $2.199B | 69.71 |
| Integra LifeSciences Holdings (IART) | United States | $2.016B | 10.53 |
| Alphatec Holdings (ATEC) | United States | $1.710B | 0.00 |
| Artivion (AORT) | United States | $1.309B | 86.72 |
| RxSight (RXST) | United States | $1.273B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.214B | 0.00 |
| Paragon 28 (FNA) | United States | $1.088B | 0.00 |
| OPKO Health (OPK) | United States | $1.024B | 0.00 |
| AxoGen (AXGN) | United States | $0.806B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.795B | 13.51 |
| IRadimed (IRMD) | United States | $0.759B | 40.99 |
| Mesa Laboratories (MLAB) | United States | $0.743B | 17.51 |
| SiBone (SIBN) | United States | $0.722B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.715B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.649B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.602B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.504B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.500B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.491B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.483B | 25.41 |
| NeuroPace (NPCE) | United States | $0.438B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.429B | 23.23 |
| Pacific Biosciences Of California (PACB) | United States | $0.427B | 0.00 |
| CVRx (CVRX) | United States | $0.409B | 0.00 |
| Inogen (INGN) | United States | $0.298B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.255B | 0.00 |
| Accuray (ARAY) | United States | $0.223B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.214B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.197B | 0.00 |
| Nevro (NVRO) | United States | $0.190B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.129B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.110B | 11.75 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.096B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| 908 Devices (MASS) | United States | $0.082B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.076B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | Israel | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.059B | 30.86 |
| EnVVeno Medical (NVNO) | United States | $0.055B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Microbot Medical (MBOT) | United States | $0.036B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.022B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |